MICROBIOPHARM JAPAN CO LTD

Overview

MICROBIOPHARM JAPAN CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering CALCITRIOL; DAUNORUBICIN HYDROCHLORIDE (CRUDE); DOXORUBICIN HYDROCHLORIDE; EPIRUBICIN HYDROCHLORIDE.

API / Drug Master Files

MICROBIOPHARM JAPAN CO LTD holds 4 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• EPIRUBICIN HYDROCHLORIDEActive2008-09-19
• CALCITRIOLActive2000-10-31
• DOXORUBICIN HYDROCHLORIDEActive1998-04-30
• DAUNORUBICIN HYDROCHLORIDE (CRUDE)Active1996-02-29
• PARICALCITOL, USPInactive2013-05-04
• MITOMYCINInactive1998-09-01
• (1S,3R)-1,3-BIS(TERT-BUTYLDIMETHYLSILYLOXY) ANDROST-5-EN-17-ONE (SI-HDEA)Inactive1996-07-08

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MICROBIOPHARM JAPAN CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.